Page 33 - 南京医科大学学报自然科学版
P. 33
第41卷第3期 南京医科大学学报(自然科学版)
2021年3月 Journal of Nanjing Medical University(Natural Sciences) ·339 ·
·基础研究·
CD109在口腔鳞状细胞癌中的表达及其临床意义
侯德强 ,白 宁 ,魏子程 ,程 洋 ,刘彦魁 ,汤根兄 4*
1
3
1
2
1
江南大学附属医院口腔科,江苏 无锡 214000;江南大学无锡医学院公共卫生与预防医学系,江苏 无锡 214000;江南
1 2 3
大学附属医院病理科,江苏 无锡 214000;南京医科大学附属儿童医院口腔科,江苏 南京 210008
4
[摘 要] 目的:研究白细胞分化抗原109(cluster of differentiation 109,CD109)在口腔鳞状细胞癌(oral squamous cell carcino⁃
ma,OSCC)中的表达并探讨其与患者临床特征及预后的关系。方法:采用实时定量PCR和免疫组织化学法检测OSCC组织中
CD109 mRNA 和蛋白的表达;结合临床病理资料分析 CD109 表达与临床特征及患者预后的关系。结果:在 OSCC 组织中,
CD109的mRNA和蛋白表达水平明显高于癌旁组织(P<0.05);CD109表达与淋巴结转移(P=0.019)、远处转移(P=0.007)和美
国癌症联合委员会癌症分期(P=0.031)相关;多因素分析证实 CD109 表达水平是 OSCC 患者的独立预后因素(P<0.001);与
CD109低或无表达的OSCC患者相比,CD109高表达的OSCC患者总生存期更短(P=0.004)。结论:CD109是影响患者预后的独
立危险因素,可能成为判断OSCC预后的肿瘤标志物。
[关键词] CD109;口腔鳞状细胞癌;预后;组织芯片
[中图分类号] R739.81 [文献标志码] A [文章编号] 1007⁃4368(2021)03⁃339⁃05
doi:10.7655/NYDXBNS20210305
Expression and clinical significance of CD109 in oral squamous cell carcinoma
3
1
2
1
1
HOU Deqiang ,BAI Ning ,WEI Zicheng ,CHENG Yang ,LIU Yankui ,TANG Genxiong 4*
1 Department of Stomatology,Affiliated Hospital of Jiangnan University,Wuxi 214000;Department of Public Health
2
3
and Preventive Medicine,Wuxi Medical College,Jiangnan University,Wuxi 214000;Department of Pathology,
Affiliated Hospital of Jiangnan University,Wuxi 214000;Department of Stomatology,the Affiliated Children’s
4
Hospital of Nanjing Medical University,Nanjing 210008,China
[Abstract] Objective: This study aims to investigate the expression of CD109 in oral squamous cell carcinoma(OSCC)and its
influence on clinical characteristics and prognosis. Methods:The expression of CD109 mRNA and protein in OSCC tissues were
detected by real ⁃ time quantitative PCR and immunohistochemistry respectively. The relationships between CD109 expression and
clinical characteristics and prognosis were analyzed according to clinicopathological data. Results:The mRNA and protein expression
levels of CD109 in OSCC tissues were significantly higher than those in paracancerous oral tissues. CD109 expression was associated
with lymph node metastasis(P=0.019),distant metastasis(P=0.007)and cancer stage according to American Joint Committee(P=
0.031). Multivariate analysis confirmed that CD109 expression was an independent prognostic factor for OSCC patients(P < 0.001).
OSCC patients with high CD109 expression had a poor overall survival compared with patients with low or none CD109 expression(P=
0.004). Conclusion:CD109 is an independent risk factor affecting the prognosis of OSCC patients,and may be an important marker to
predict the prognosis of OSCC.
[Key words] CD109;oral squamous cell carcinoma;prognosis;tissue microarray
[J Nanjing Med Univ,2021,41(03):339⁃343]
口腔鳞状细胞癌(oral squamous cell carcinoma,
[基金项目] 无锡市卫健委科研项目(MS201909);太湖高层
OSCC)是世界上最常见的恶性肿瘤之一,约 60%的
次人才(双百中青年医疗卫生拔尖人才)(BJ2020056)
[1]
∗ 患者发生局部复发,5年生存率较差 。临床亟需可
通信作者(Corresponding author),E⁃mail: 13813808983@139.
com 用于OSCC诊断和治疗的特异性预后标志物。白细